ZYME ZYMEWORKS INC
FollowCOM (common), issuer CIK 1937653
Filings received so far for Q3 2026: 3 13F filers report a position in ZYME shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Schayowitz Adamofficer (EVP, Head of R&D) | 2026-10-09 | -13,832 S | $25.85 | Form 4 |
| Schayowitz Adamofficer (EVP, Head of R&D) | 2026-10-09 | +37,037 M | $0 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GAMMA Investing LLC | 1,176 | $31.2K | <0.01% | +62 | 13F-HRTimeline |
| Versant Capital Management, Inc | 94 | $2.49K | <0.01% | +49 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 52 | $1.38K | <0.01% | +22 | 13F-HRTimeline |
Events
Schayowitz Adam acquired 23,205 ZYME shares on 2026-10-09, Form 4 filed 2026-10-09. 0002127119-26-000006
Accepted , ingested